Californian connected healthcare firm VivaLNK is working with Amps, a producer of software tools for electrocardiograms (ECGs), to advance remote patient monitoring for clinical trials.

New York-based Amps’ continuous ECG recording suite combined with VivaLNK medical wearable sensors provide real-time and retrospective analysis for continuous ECG datasets in remote environments.

VivaLNK and Amps most recently partnered for a ten-year, 3000 subject University of California, San Francisco (UCSF) clinical trial aiming to detect biomarkers of early atrial transformation on atrial fibrillation (AFib).

For the study, Amps is collecting and processing the ECG data from VivaLNK’s medical wearable sensors, which can capture ECG and heart rate continuously 24 hours a day. Each subject will wear the ECG sensor for about one week every month, while mobile or at home, and data from the sensor will then be captured through a mobile app and sent to the cloud for analysis.

Continuous monitoring is particularly crucial for detecting and reporting AFib, as other methods can miss an episode, providing inaccurate results.

“Our cohesive solution combined with the Amps software application provides a winning combination for pharmaceutical companies requiring effective RPM for patient studies,” said Jiang Li, CEO of VivaLNK. “We look forward to continuing this partnership and our combined uses across additional clinical trials in the years to come.”

VivaLNK’s continuous ECG platform has also been seamlessly integrated with the Amps’ continuous ECG recording suite, allowing for the direct analysis of recorded data.

“Our ECG analysis software has been used to measure millions of ECGs worldwide, and we take that role very seriously because of the implications it has on studies and the medical community,” said Fabio Badilini, chief scientist at Amps. “The integration with VivaLNK’s medical wearable ECG sensor provides a unique solution for remote cardiac monitoring.”

VivaLNK provides connected healthcare for wellness, patient care and telemedicine. The company’s portfolio includes wearable medical grade devices and data analytics applications that continuously monitor the health and well-being of individuals.

Amps provides software for the display and analysis of ECG traces and blood pressure monitoring. Originally focused on the needs of clinical research organisations and pharmaceutical corporations in the context of clinical trials for new drugs, Amps has expanded into the medical world with a set of tools for healthcare. It has been investing for the past 18 years more than half of its annual revenues in R&D activities.